Sertraline use in mitochondrial cytopathy-associated depression: A case report

Durak, Mehri; Ates, Burcin Ozlem

doi:10.14744/DAJPNS.2026.00329

Letter to The Editor

Sertraline use in mitochondrial cytopathy-associated depression: A case report

Mehri Durak ¹

, Burcin Ozlem Ates ¹

¹Gulhane Training and Research Hospital, Department of Child and Adolescent Psychiatry, Ankara, Turkiye

Dusunen Adam J Psychiatr Neurol Sci 2026; 39(2): 156-158 DOI: 10.14744/DAJPNS.2026.00329

Full Text PDF

Durak M, Ates BO. Sertraline use in mitochondrial cytopathy-associated depression: A case report. Dusunen Adam J Psychiatr Neurol Sci. 2026 ;39(2):156-158. doi: 10.14744/DAJPNS.2026.00329.

Durak M, Ates BO. Sertraline use in mitochondrial cytopathy-associated depression: A case report. Dusunen Adam J Psychiatr Neurol Sci. 2026;39(2):156-158. doi: 10.14744/DAJPNS.2026.00329

Durak, M., & Ates, B. O. (2026). Sertraline use in mitochondrial cytopathy-associated depression: A case report. Dusunen Adam Journal of Psychiatry and Neurological Sciences, 39(2), 156-158. https://doi.org/10.14744/DAJPNS.2026.00329

Durak, M., and B. O. Ates. "Sertraline use in mitochondrial cytopathy-associated depression: A case report." Dusunen Adam Journal of Psychiatry and Neurological Sciences, vol. 39, no. 2, 2026, pp. 156-158. https://doi.org/10.14744/DAJPNS.2026.00329.

Durak, M., B. O. Ates. 2026. "Sertraline use in mitochondrial cytopathy-associated depression: A case report." Dusunen Adam Journal of Psychiatry and Neurological Sciences 39, no. 2: 156-158. https://doi.org/10.14744/DAJPNS.2026.00329.

Journal Display Format:

Authors: Mehri Durak, Burcin Ozlem Ates
Article Title: Sertraline use in mitochondrial cytopathy-associated depression: A case report
Journal Name: Dusunen Adam Journal of Psychiatry and Neurological Sciences
Year: 2026
Volume: 39
Issue: 2
Pages: 156 - 158
DOI: 10.14744/DAJPNS.2026.00329

RIS BibTeX EndNote Medlars